218 related articles for article (PubMed ID: 9469348)
21. Evaluation of tumour metabolism and multidrug resistance in patients with treated malignant lymphomas.
Dimitrakopoulou-Strauss A; Strauss LG; Goldschmidt H; Lorenz WJ; Maier-Borst W; van Kaick G
Eur J Nucl Med; 1995 May; 22(5):434-42. PubMed ID: 7641752
[TBL] [Abstract][Full Text] [Related]
22. Patients undergoing multiple
Indrakanti S; Li X; Rehani MM
Br J Radiol; 2022 Jul; 95(1135):20211225. PubMed ID: 35348374
[TBL] [Abstract][Full Text] [Related]
23. [Positron emission tomography (PET) in diagnosis and therapy planning of malignant lymphoma].
Dimitrakopoulou-Strauss A; Strauss LG; Goldschmidt H; Hegenbart U; Irngartinger G; Oberdorfer F; van Kaick G
Radiologe; 1997 Jan; 37(1):74-80. PubMed ID: 9157479
[TBL] [Abstract][Full Text] [Related]
24. Detection of bone marrow infiltration by non-Hodgkin's lymphoma--comparison of histological findings, analysis of gene rearrangements, and examination by magnetic resonance imaging.
Knauf WU; Gückel F; Döhner H; Semmler W; Trümper L; Ho AD
Klin Wochenschr; 1991 May; 69(8):345-50. PubMed ID: 1653380
[TBL] [Abstract][Full Text] [Related]
25.
Bashank N; Sharef S; Mohran TZ; Khalil M
EJNMMI Rep; 2024 Apr; 8(1):8. PubMed ID: 38748324
[TBL] [Abstract][Full Text] [Related]
26. [18F] FDG PET in gastric non-Hodgkin's lymphoma.
Rodriguez M; Ahlström H; Sundín A; Rehn S; Sundström C; Hagberg H; Glimelius B
Acta Oncol; 1997; 36(6):577-84. PubMed ID: 9408147
[TBL] [Abstract][Full Text] [Related]
27. Usefulness of FDG-PET in diagnosing primary lymphoma of the liver.
Bangerter M; Moog F; Griesshammer M; Merkle E; Hafner M; Ellenrieder V; Reske SN; Heimpel H
Int J Hematol; 1997 Dec; 66(4):517-20. PubMed ID: 9479878
[TBL] [Abstract][Full Text] [Related]
28. Positron emission tomography in non-Hodgkin's lymphoma: assessment of chemotherapy with fluorodeoxyglucose.
Römer W; Hanauske AR; Ziegler S; Thödtmann R; Weber W; Fuchs C; Enne W; Herz M; Nerl C; Garbrecht M; Schwaiger M
Blood; 1998 Jun; 91(12):4464-71. PubMed ID: 9616140
[TBL] [Abstract][Full Text] [Related]
29. Magnetic resonance imaging of bone marrow in lymphoproliferative disorders: correlation with bone marrow biopsy.
Döhner H; Gückel F; Knauf W; Semmler W; van Kaick G; Ho AD; Hunstein W
Br J Haematol; 1989 Sep; 73(1):12-7. PubMed ID: 2679859
[TBL] [Abstract][Full Text] [Related]
30. Detection of lymphomatous bone marrow involvement with magnetic resonance imaging.
Hoane BR; Shields AF; Porter BA; Shulman HM
Blood; 1991 Aug; 78(3):728-38. PubMed ID: 1859885
[TBL] [Abstract][Full Text] [Related]
31. Use of carbon-11 methionine positron emission tomography to assess malignancy grade and predict survival in patients with lymphomas.
Nuutinen J; Leskinen S; Lindholm P; Söderström KO; Någren K; Huhtala S; Minn H
Eur J Nucl Med; 1998 Jul; 25(7):729-35. PubMed ID: 9662595
[TBL] [Abstract][Full Text] [Related]
32. Bilateral trephine bone marrow biopsies in Hodgkin's and non-Hodgkin's lymphoma.
Menon NC; Buchanan JG
Pathology; 1979 Jan; 11(1):53-7. PubMed ID: 431979
[TBL] [Abstract][Full Text] [Related]
33. FDG-PET for predicting the prognosis of malignant lymphoma.
Okada J; Oonishi H; Yoshikawa K; Itami J; Uno K; Imaseki K; Arimizu N
Ann Nucl Med; 1994 Aug; 8(3):187-91. PubMed ID: 7811561
[TBL] [Abstract][Full Text] [Related]
34. Increased glucose metabolism in untreated non-Hodgkin's lymphoma: a study with positron emission tomography and fluorine-18-fluorodeoxyglucose.
Lapela M; Leskinen S; Minn HR; Lindholm P; Klemi PJ; Söderström KO; Bergman J; Haaparanta M; Ruotsalainen U; Solin O; Joensuu H
Blood; 1995 Nov; 86(9):3522-7. PubMed ID: 7579459
[TBL] [Abstract][Full Text] [Related]
35. [MR tomography detection of bone marrow infiltration by malignant lymphomas].
Gückel F; Döhner H; Knauf W; Ho AD; Semmler W; van Kaick G
Onkologie; 1989 Aug; 12 Suppl 1():34-7. PubMed ID: 2685693
[TBL] [Abstract][Full Text] [Related]
36. Detection of unsuspected recurrent lymphoma with fluorodeoxyglucose-positron emission tomographic imaging after induction chemotherapy: a case study.
Alavi JB; Bénard F; Alavi A
Am J Clin Oncol; 1998 Apr; 21(2):126-8. PubMed ID: 9537195
[TBL] [Abstract][Full Text] [Related]
37. Correlation of CT-guided fine-needle aspiration biopsy of the liver with fluoride-18 fluorodeoxyglucose positron emission tomography in the assessment of metastatic hepatic abnormalities.
Collins BT; Lowe VJ; Dunphy FR
Diagn Cytopathol; 1999 Jul; 21(1):39-42. PubMed ID: 10405807
[TBL] [Abstract][Full Text] [Related]
38. Bilateral trephine bone marrow biopsies in lymphoma and other neoplastic diseases.
Brunning RD; Bloomfield CD; McKenna RW; Peterson LA
Ann Intern Med; 1975 Mar; 82(3):365-6. PubMed ID: 1172924
[TBL] [Abstract][Full Text] [Related]
39. Hematopoietic cytokine-mediated FDG uptake simulates the appearance of diffuse metastatic disease on whole-body PET imaging.
Hollinger EF; Alibazoglu H; Ali A; Green A; Lamonica G
Clin Nucl Med; 1998 Feb; 23(2):93-8. PubMed ID: 9481497
[TBL] [Abstract][Full Text] [Related]
40. Bone marrow biopsy for the staging of non-Hodgkin's lymphoma: bilateral or unilateral trephine biopsy?
Luoni M; Declich P; De Paoli Af1p4 ; Fava S; Marinoni P; Montalbetti L; Sangalli G; Sciuccati P; Tocci A; Tosi A
Tumori; 1995; 81(6):410-3. PubMed ID: 8804465
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
